DrugDashboards

brivaracetam

brivaracetam · BRIVARACETAM 50 mg/1 · Tablet, Film Coated · Oral · AvKARE

NDC 73190-0075-60 · 60 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 50474-0570-66) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$24.21per unit
middle half $23.88–$25.23 · 5,484 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $24.21
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 5 · prior auth 70% · step therapy 1% · qty limit 93%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for brivaracetam (oral solid) in the next 90 days

sole-source market · price up 3% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $1,602.73 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA214921
TE code
AB
Approval date
Nov 13, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of brivaracetam (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedBRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedBRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
AvKAREBRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
AvKAREBRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
AvKAREBRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
AvKAREBRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCBRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCBRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCBRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCBRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCBRIVARACETAM 10 mg/1Jul 15, 2026Sep 2, 2026
SolarisPharmaCorporationBRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
SolarisPharmaCorporationBRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
SolarisPharmaCorporationBRIVARACETAM 10 mg/1Jul 15, 2026Sep 2, 2026
SolarisPharmaCorporationBRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
SolarisPharmaCorporationBRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
UCB Pharma S.A.BRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
UCB Pharma S.A.BRIVARACETAM 10 mg/1Jul 15, 2026Sep 2, 2026
UCB Pharma S.A.BRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
UCB Pharma S.A.BRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
UCB Pharma S.A.BRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
UCB, Inc.BRIVARACETAM 10 mg/1Jul 15, 2026Sep 2, 2026
UCB, Inc.BRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
UCB, Inc.BRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
UCB, Inc.BRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
UCB, Inc.BRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedBRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedBRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedBRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedBRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedBRIVARACETAM 10 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.BRIVARACETAM 100 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.BRIVARACETAM 75 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.BRIVARACETAM 10 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.BRIVARACETAM 50 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.BRIVARACETAM 25 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedBRIVARACETAM 10 mg/1Jul 18, 2026Aug 29, 2026
Aurobindo Pharma LimitedBRIVARACETAM 75 mg/1Jul 18, 2026Aug 29, 2026
Aurobindo Pharma LimitedBRIVARACETAM 25 mg/1Jul 18, 2026Aug 29, 2026
ScieGen Pharmaceuticals, Inc.BRIVARACETAM 25 mg/1Jul 24, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "brivaracetam — NDC 73190-0075-60," retrieved September 3, 2026, https://drugdashboards.com/drug/73190007560.

Free to cite with attribution — see how the data is put together.